CAMP-dependent proteolysis of GATA-6 is linked to JNK-signaling pathway

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 679-683

  Ushijima, Hironori ^a   Maeda, Masatomo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Anisomycin; CAMP; GATA 6; JNK; Nuclear export; Proteasome

Indexed keywords

ANISOMYCIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIC AMP; EXPORTIN 1; LEPTOMYCIN B; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR GATA 6;

ARTICLE; CYTOPLASM; DRUG ANTAGONISM; DRUG EFFECT; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTHRACENES; ANTIBIOTICS, ANTINEOPLASTIC; CHO CELLS; CRICETINAE; CYCLIC AMP; FATTY ACIDS, UNSATURATED; GATA6 TRANSCRIPTION FACTOR; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEOLYSIS; RATS;

EID: 84863845947     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.013     Document Type: Article

References (34)

1. Tamura S., Wang X.H., Maeda M., Futai M. Gastric DNA-binding proteins recognize upstream sequence motifs of parietal cell-specific genes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10876-10880.
2. Yoshida T., Sato R., Mahmood S., Kawasaki S., Futai M., Maeda M. GATA-6 DNA binding protein expressed in human gastric adenocarcinoma MKN45 cells. FEBS Lett. 1997, 414:333-337.
3. Maeda M., Ohashi K., Ohashi-Kobayashi A. Further extension of mammalian GATA-6. Develop. Growth Differ. 2005, 47:591-600.
4. Nakagawa R., Sato R., Futai M., Yokosawa H., Maeda M. Gastric GATA-6 DNA-binding protein: proteolysis induced by cAMP. FEBS Lett. 1997, 408:301-305.
5. Ishida A., Iijima R., Kobayashi A., Maeda M. Characterization of cAMP-dependent proteolysis of GATA-6. Biochem. Biophys. Res. Commun. 2005, 332:976-981.
6. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 1997, 17:2550-2558.
7. Su K., Roos M.D., Yang X., Han I., Paterson A.J., Kudlow J.E. An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 1999, 274:15194-15202.
8. Tsuge T., Uetani K., Sato R., Ohashi-Kobayashi A., Maeda M. Cyclic AMP-dependent proteolysis of GATA-6 expressed on the intracellular membrane. Cell Biol. Int. 2008, 32:298-303.
9. Maeda M., Ishida A., Ni L., Kobayashi A. Isolation of CHO-K1 clones defective in cAMP-dependent proteolysis, as determined by the stability of exogenously expressed GATA-6. Biochem. Biophys. Res. Commun. 2005, 329:140-146.
10. Robinson-White A., Stratakis C.A. Protein kinase A signaling " cross-talk" with other pathways in endocrine cells. Ann. N.Y. Acad. Sci. 2002, 968:256-270.
11. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
12. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
13. Manning A.M., Davis R.J. Targeting JNK for therapeutic benefit: Junk to Gold. Nat. Rev. Drug Discovery 2003, 2:554-565.
14. Sobin B.A., Tanner F.W. Anisomycin, a new anti-protozoan antibiotic. J. Am. Chem. Soc. 1954, 76:4053.
15. Rosser E.M., Morton S., Ashton K.S., Cohen P., Hulme A.N. Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways. Org. Biomol. Chem. 2004, 2:142-149.
16. SCADS inhibitor kit: < http://gantoku-shien.jfcr.or.jp/kit.html>.
17. Fukasawa M., Nishijima M., Itabe H., Takano T., Hanada K. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta-cyclodextrin. J. Biol. Chem. 2000, 275:34028-34034.
18. Lund E., Güttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear Export of MicroRNA Precursors. Science 2004, 303:95-98.
19. +-ATPase in colorectal cancer cells. Biol. Pharm. Bull. 2007, 30:648-654.
20. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. second ed.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 1972, 227:680-685.
23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4350-4354.
24. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 1990, 265:5267-5272.
25. Lu Z.X., Quazi N.H., Deady L.W., Polya G.M. Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives. Biol. Chem. Hoppe-Seyler 1996, 377:373-384.
26. Montminy M. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 1997, 66:807-822.
27. Nishi K., Yoshida M., Fujiwara D., Nishikawa M., Horinouchi S., Beppu T. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 1994, 269:6320-6324.
28. Lingbeck J.M., Trausch-Azar J.S., Ciechanover A., Schwartz A.L. Determination of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J. Biol. Chem. 2003, 278:1817-1823.
29. Güttler T., Görlich D. Ran-dependent nuclear export mediators: a structural perspective. EMBO J. 2011, 30:3457-3474.
30. Farjot G., Sergeant A., Mikaélian I. A new nucleoporin-like protein 1 interacts with both HIV-1 Rev nuclear export signal and CRM-1. J. Biol. Chem. 1999, 274:17309-17317.
31. NES Finder 0.2:< http://research.nki.nl/fornerodlab/NES-Finder.htm >.
32. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol. Endocrinol. 2002, 16:2382-2392.
33. Shureiqi I., Jiang W., Fischer S.M., Xu X., Chen D., Lee J.J., Lotan R., Lippman S.M. GATA-6 transcription regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res. 2002, 62:1178-1183.
34. Shureiqi I., Zuo X., Broaddus R., Wu Y., Guan B., Morris J.S., Lippman S.M. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2007, 21:743-752.